Skip to main content
Livermore
Livermore
ZHEN

Janus Henderson Group PLC

SEC CIK
0001274173
Latest filing
May 18, 2026

ASND holding history

Ascendis Pharma A/S in every 13F filed by Janus Henderson Group PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overviewAll 13F holders of ASNDFull Q1 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of ASND by Janus Henderson Group PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−4,061,641−100.0%Sold outHolders
Q4 20254,061,641$866.1M0.4%−261,418−6.0%ReducedHolders
Q3 20254,323,059$859.4M0.4%−104,733−2.4%ReducedHolders
Q2 20254,427,792$764.4M0.4%−59,157−1.3%ReducedHolders
Q1 20254,486,949$694.0M0.4%+106,567+2.4%AddedHolders
Q4 20244,380,382$602.9M0.3%+193,688+4.6%AddedHolders
Q3 20244,186,694$625.1M0.3%+267,881+6.8%AddedHolders
Q2 20243,918,813$534.5M0.3%+151,610+4.0%AddedHolders
Q1 20243,767,203$569.4M0.3%−227,582−5.7%ReducedHolders
Q4 20233,994,785$503.1M0.3%+140,252+3.6%AddedHolders
Q3 20233,854,533$361.0M0.2%−26,829−0.7%ReducedHolders
Q2 20233,881,362$346.5M0.2%+348,532+9.9%AddedHolders
Q1 20233,532,830$378.8M0.2%−111,125−3.0%ReducedHolders
Q4 20223,643,955$445.0M0.3%−192,803−5.0%ReducedHolders
Q3 20223,836,758$396.2M0.3%−24,501−0.6%ReducedHolders
Q2 20223,861,259$359.0M0.2%+445,732+13.1%AddedHolders
Q1 20223,415,527$400.8M0.2%+195,562+6.1%AddedHolders
Q4 20213,219,965$433.2M0.2%−31,702−1.0%ReducedHolders
Q3 20213,251,667$518.3M0.2%+124,496+4.0%AddedHolders
Q2 20213,127,171$411.4M0.2%−40,141−1.3%ReducedHolders
Q1 20213,167,312$408.2M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.